Valeant Pharmaceuticals jumped to new all-time highs in huge volume Thursday after issuing bullish guidance for 2015. The stock is extended from a 135.68 handle buy point but also shows a higher entry past 147.49. It is in a buy range about 4% past this entry. Early Thursday, Valeant (VRX) hosted a conference call providing an update on 2014 developments along with 2015 financial guidance.